• Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead Realasset Realasset
moneycontrol.com
Houseviews: Brokerages bullish on Hindustan Zinc, Shriram City, Tech Mahindra
  • 
	Hindustan Zinc 

	Brokerage: Credit Suisse

	Rating: Outperform

	Target: Rs 151

	Rationale: They expect a sharp increase in zinc prices in the year.

	 

    Hindustan Zinc Brokerage: Credit Suisse Rating: Outperform Target: Rs 151 Rationale: They expect a sharp increase in zinc prices in the year.  

  • 
	Shriram City Union 

	Brokerage: Religare

	Rating: Buy

	Target: Rs 1200

	Rationale: While AUM growth could be subdued in the near term due to adjustments in the gold loan portfolio, Religare is positive on the stock due to its niche presence and small base.

    Shriram City Union Brokerage: Religare Rating: Buy Target: Rs 1200 Rationale: While AUM growth could be subdued in the near term due to adjustments in the gold loan portfolio, Religare is positive on the stock due to its niche presence and small base.

  • 
	Tech Mahindra 

	Brokerage: Goldman sachs

	Rating: Buy

	Target: Rs 1300 

	Rationale: The stock is trading at attractive valuations, at a 31 percent discount to HCL Tech, its closest peer in terms of scale. 

    Tech Mahindra Brokerage: Goldman sachs Rating: Buy Target: Rs 1300  Rationale: The stock is trading at attractive valuations, at a 31 percent discount to HCL Tech, its closest peer in terms of scale. 

  • 
	Apollo Hospitals 

	Brokerage: JPMorgan 

	Rating: Neutral

	Target: Rs 900

	Rationale: Further multiple expansion would need catalysts like divestment of the pharmacy business or an exit from its non-core insurance joint venture.

    Apollo Hospitals Brokerage: JPMorgan  Rating: Neutral Target: Rs 900 Rationale: Further multiple expansion would need catalysts like divestment of the pharmacy business or an exit from its non-core insurance joint venture.

  • 
	Hindustan Zinc 

	Brokerage: Credit Suisse

	Rating: Outperform

	Target: Rs 151

	Rationale: They expect a sharp increase in zinc prices in the year.

	 
  • 
	Shriram City Union 

	Brokerage: Religare

	Rating: Buy

	Target: Rs 1200

	Rationale: While AUM growth could be subdued in the near term due to adjustments in the gold loan portfolio, Religare is positive on the stock due to its niche presence and small base.
  • 
	Tech Mahindra 

	Brokerage: Goldman sachs

	Rating: Buy

	Target: Rs 1300 

	Rationale: The stock is trading at attractive valuations, at a 31 percent discount to HCL Tech, its closest peer in terms of scale. 
  • 
	Apollo Hospitals 

	Brokerage: JPMorgan 

	Rating: Neutral

	Target: Rs 900

	Rationale: Further multiple expansion would need catalysts like divestment of the pharmacy business or an exit from its non-core insurance joint venture.

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login